Praxis Launches Patient Recruitment Campaign for a Rheumatoid Arthritis Medical Research Study

Brentwood, TN -- Nov. 9, 2004 -- Praxis, a company specializing in centralized patient recruitment for clinical research studies, is providing services to a major biotech company for a medical research study taking place in 50 sites across the United States. The recruitment period will last four months for this Phase II study, which will investigate the safety and effectiveness of a possible treatment for rheumatoid arthritis, an autoimmune disease that affects 2.1 million Americans.

Praxis is providing a variety of patient recruitment services for this clinical research study, including website development, print and radio advertising, patient education materials, and centralized inquiry fulfillment.

“This study expands our expertise within the autoimmune disease category,” said David Fox, president and CEO of Praxis. “Our targeted approach will help the sponsor to meet their recruitment goals for this study on schedule,” added Fox.

Praxis Communications, Inc., headquartered in Brentwood, TN, provides the pharmaceutical and biotech industries with a wide range of services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management. For more information, call Praxis at (615) 312-8207.

> Back to Press Release archive